Table 2 i2b2 Obesity NLP reference evaluation.
Condition | Se | Sp | D(s) |
|---|---|---|---|
Asthma | 92.7% | 99.1% | 3.8 |
CAD | 75.5% | 99.4% | 5.0 |
Congestive heart failure (CHF) | 74.2% | 99.4% | 5.5 |
Depression | 69.9% | 100% | 5.6 |
Diabetes mellitus | 82.0% | 99.2% | 67.3 |
Gallstones / Cholcystectomy | 81.2% | 98.7% | 4.9 |
GERD | 56.2% | 100% | 4.8 |
Gout | 94.4.% | 100% | 8.7 |
Hypercholesterolemia | 82.4% | 100% | 4.9 |
Hypertension | 82.6 % | 98.6% | 8.4 |
Hypertriglyceridemia | 60.0% | 98.8% | 0.9 |
Obstructive sleep apnea (OSA) | 100 % | 100 % | 1.5 |
Osteoarthritis | 61.2% | 98.9% | 2.3 |
Peripheral vascular disease | 66.3 % | 99.4% | 1.1 |
Venous insufficiency | 77.8% | 99.1% | 2.8 |
Obesity | 86.1% | 99.2% | 0.6 |
Average | 77.3% | 99.1% | 8.0 |